These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1923216)

  • 1. Modified posterior exenteration for ovarian cancer.
    Eisenkop SM; Nalick RH; Teng NN
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):879-85. PubMed ID: 1923216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
    Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
    Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis.
    Mirhashemi R; Averette HE; Estape R; Angioli R; Mahran R; Mendez L; Cantuaria G; Penalver M
    Am J Obstet Gynecol; 2000 Dec; 183(6):1375-9; discussion 1379-80. PubMed ID: 11120499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pelvic posterior exenteration with immediate colo-rectal anastomosis: is it justified and feasible in advanced stage ovarian carcinoma?].
    Buttarelli M; Houvenaeghel G; Lelièvre L; Jacquemier J; Guiramand J; Delpero JR
    Ann Chir; 2006 Oct; 131(8):431-6. PubMed ID: 16707093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer.
    Aletti GD; Podratz KC; Jones MB; Cliby WA
    J Am Coll Surg; 2006 Oct; 203(4):521-6. PubMed ID: 17000396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator.
    Bristow RE; Montz FJ
    Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary cytoreductive surgery of advanced ovarian cancer with special reference to the significance of bowel resection].
    Sato K; Horiguchi M; Kimura M; So E; Kojima T; Tamuna M; Shima Y; Numaguchi M; Uno K; Maru H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1070-7. PubMed ID: 2730012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. En bloc pelvic peritoneal resection of the intraperitoneal pelvic viscera in patients with advanced epithelial ovarian cancer.
    Sainz de la Cuesta R; Goodman A; Halverson SS
    Cancer J Sci Am; 1996; 2(3):152-7. PubMed ID: 9166515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer.
    Berek JS; Hacker NF; Lagasse LD
    Obstet Gynecol; 1984 Nov; 64(5):715-20. PubMed ID: 6387559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer.
    Yildirim Y; Ertas IE; Nayki U; Ulug P; Nayki C; Yilmaz I; Gultekin E; Dogan A; Aykas A; Ulug S; Ozdemir A; Solmaz U
    Eur J Gynaecol Oncol; 2014; 35(4):400-7. PubMed ID: 25118481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancer.
    Tixier H; Fraisse J; Chauffert B; Mayer F; Causeret S; Loustalot C; Deville C; Bonnetain F; Sagot P; Douvier S; Cuisenier J
    Arch Gynecol Obstet; 2010 Mar; 281(3):505-10. PubMed ID: 19847452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical technique of en bloc pelvic resection for advanced ovarian cancer.
    Chang SJ; Bristow RE
    J Gynecol Oncol; 2015 Apr; 26(2):155. PubMed ID: 25872895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
    Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
    Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenteration. Has it a role in 1987? A six year experience.
    Shepherd JH
    Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
    Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
    Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.